All individual Trials
Trials reported
16135 out of 20855
Percent reported
77.4%
US Govt could have imposed fines of at least
$62,988,588,969
Fines claimed by US Govt
$0
Showing 1 to 100 of 39,871 entries
Status | Sponsor | Trial ID | Title | Completion date | Days overdue |
---|---|---|---|---|---|
reported-late | M.D. Anderson Cancer Center | NCT01891968 | Phase II Study of Subcutaneous Bortezomib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome [pACT] | 2017-01-18 | 25 |
reported-late | University of California, San Diego | NCT02251236 | Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals [pACT] | 2017-01-18 | 628 |
reported-late | Montefiore Medical Center | NCT02127073 | Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer [pACT] | 2017-01-18 | 2097 |
overdue | Jiangsu Yahong Meditech Co., Ltd aka Asieris | NCT04498702 | A Phase II Single-Arm, Open-Label, Multi-Center Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy [pACT] | 2017-01-18 | 2213 |
reported | Bristol-Myers Squibb | NCT02413372 | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis [pACT] | 2017-01-18 | |
overdue | Delta-Fly Pharma, Inc. | NCT01702155 | A Phase I/II Study of DFP 10917 Given by Continuous Infusion in Patients With Relapsed or Refractory Acute Leukemia [pACT] | 2017-01-18 | 2213 |
reported | Bristol-Myers Squibb | NCT03400163 | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple Dose Sub-study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Adults With Non-alcoholic Steatohepatitis [pACT] | 2017-01-18 | |
reported-late | Stryker Spine | NCT02704689 | A Prospective Multi-Center Evaluation of a Hydraulic Expandable TLIF Cage for the Treatment of Degenerative Disc Disease of the Lumbar Spine [pACT] | 2017-01-19 | 62 |
reported | Brigham and Women's Hospital | NCT01275365 | Optimizing Protein Intake in Older Americans With Mobility Limitations [pACT] | 2017-01-19 | |
reported-late | Sofya Pintova | NCT01985763 | Genistein Combined With FOLFOX or FOLFOX-Avastin for Treatment of Metastatic Colorectal Cancer: Phase I/II Pilot Study [pACT] | 2017-01-19 | 431 |
reported | Gilead Sciences | NCT02291237 | Study Title: A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of GS-6615 on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy [pACT] | 2017-01-20 | |
reported | Vertex Pharmaceuticals Incorporated | NCT02347657 | A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation [pACT] | 2017-01-20 | |
reported | Wake Forest University Health Sciences | NCT03057704 | Comparison of Two Techniques of Administering IV Lidocaine in Reducing Propofol Injection Pain [pACT] | 2017-01-20 | |
overdue | Shaare Zedek Medical Center | NCT04120506 | Long Term Impact of Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Adult Patients With Type 1 Gaucher Disease, Previously on a Stable Dose of VPRIV for at Least 3 Months: an Extension of the Investigator-initiated Study [pACT] | 2017-01-20 | 2211 |
reported-late | National Cancer Institute (NCI) | NCT01964924 | A Single Arm, Phase II Study of Single Agent Trametinib Followed by Trametinib in Combination With GSK2141795 in Patients With Advanced Triple Negative Breast Cancer [pACT] | 2017-01-20 | 331 |
reported-late | M.D. Anderson Cancer Center | NCT02410551 | Pacritinib Prior to Transplant for Patients With Myeloproliferative Neoplasms (MPN) [pACT] | 2017-01-20 | 39 |
reported | Stanford University | NCT01829165 | A Causal Neural Network-level Understanding of Depression and Its Treatment Through Concurrent TMS and fMRI [pACT] | 2017-01-20 | |
reported | Ulthera, Inc | NCT02736825 | Non-Inferiority Study of the Safety and Efficacy of Ultherapy® Using Standard Versus Simulines Transducers at a Reduced Energy Level for Patient Comfort [pACT] | 2017-01-20 | |
reported | Hoffmann-La Roche | NCT02609633 | Accu-Chek® CONNECT at School (CATS) Pediatric Study [pACT] | 2017-01-20 | |
reported | Masimo Corporation | NCT03124784 | Accuracy of Oxygen Saturation (SpO2) Noninvasive Pulse Oximeter Sensor (RD Disposable) Under Motion Conditions [pACT] | 2017-01-20 | |
reported-late | Columbia University | NCT01846221 | Comparison of Fentanyl-bupivacaine and Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor in Patients With Continuous Epidural Analgesia [pACT] | 2017-01-20 | 47 |
reported | AIDS Clinical Trials Group | NCT02605304 | Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens [pACT] | 2017-01-20 | |
reported-late | Clarus Therapeutics, Inc. | NCT02921386 | A Phase 2 Study of the Effect of Meals With Various Amounts of Fat Given Immediately After Dosing on the Pharmacokinetics of an Oral Testosterone Undecanoate [pACT] | 2017-01-21 | 43 |
reported | Virginia Commonwealth University | NCT02080819 | Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse [pACT] | 2017-01-21 | |
reported-late | GID BIO, Inc. | NCT02626780 | Adipose-derived Stromal Vascular Fraction (SVF) Injections to Stimulate Hair Regrowth for Androgenetic Alopecia [pACT] | 2017-01-22 | 92 |
reported-late | Elixir Medical Corporation | NCT04034121 | Non-randomized Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System in de Novo Native Coronary Artery Lesions - DESolve Cx Single-Arm Registry [pACT] | 2017-01-22 | 1187 |
reported-late | Cook Research Incorporated | NCT02535065 | Clinical Study Plan for the Zenith® Low Profile AAA Endovascular Graft [pACT] | 2017-01-23 | 78 |
reported-late | Nemours Children's Clinic | NCT02794844 | Implementation of Pharmacogenomic Testing in Nemours Children's Health System [pACT] | 2017-01-23 | 76 |
reported | Astellas Pharma Inc | NCT02308163 | Phase 3 Study of ASP015K - A Randomized, Double-blind, Placebo-controlled Confirmatory Study of the Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis Who Had an Inadequate Response to DMARDs [pACT] | 2017-01-23 | |
reported-late | Mayo Clinic | NCT02547129 | A Randomized Clinical Trial of Static Versus Articulating Antibiotic Spacer for Treatment of Periprosthetic Joint Infection in Total Knee Arthroplasty [pACT] | 2017-01-23 | 92 |
reported-late | Inovio Pharmaceuticals | NCT02163057 | Prospective Study of HPV Specific Immunotherapy in Subjects With HPV Associated Head and Neck Squamous Cell Carcinoma (HNSCCa) [pACT] | 2017-01-23 | 313 |
reported | Novartis Pharmaceuticals | NCT01870778 | A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients [pACT] | 2017-01-23 | |
reported | Idorsia Pharmaceuticals Ltd. | NCT02472795 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-response Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus [pACT] | 2017-01-23 | |
reported | Johnson & Johnson Vision Care, Inc. | NCT02886923 | Evaluation of Vision Effects of a Cosmetic Tinted Hydrogel Contact Lens [pACT] | 2017-01-23 | |
reported | Amgen | NCT02575833 | A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of AMG 334 on Exercise Time During a Treadmill Test in Subjects With Stable Angina [pACT] | 2017-01-23 | |
overdue | Associacao Protectora dos Diabeticos de Portugal | NCT04141111 | ADJUST: Impact of Professional Continuous Glucose Monitoring in People With Insulin-treated Type 2 Diabetes [pACT] | 2017-01-24 | 2207 |
reported-late | Karyopharm Therapeutics Inc | NCT02025985 | A Phase II, Open-label Study of Efficacy and Safety of the Selective Inhibitor of Nuclear Export/SINE™ Compound KPT-330 (Selinexor) in Patients With Advanced Gynaecologic Malignancies [pACT] | 2017-01-24 | 1045 |
reported | AstraZeneca | NCT02814643 | A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma. [pACT] | 2017-01-24 | |
reported | UCB Pharma | NCT01921205 | A Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy ≥4 Years to <17 Years of Age With Partial Onset Seizures [pACT] | 2017-01-24 | |
reported | Kenneth Taylor, M.D. | NCT02421419 | Pain With Trigger Finger Injection: A Comparison of Steroid Alone Versus Steroid/Lidocaine Mixture [pACT] | 2017-01-25 | |
reported | Emory University | NCT02401230 | Defining the Rectal Mucosa in Men Who Have Sex With Men at Risk of HIV Infection [pACT] | 2017-01-25 | |
reported | GlaxoSmithKline | NCT02689206 | A 29-day, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent [pACT] | 2017-01-25 | |
reported | NYU Langone Health | NCT02032433 | CTN-0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment [pACT] | 2017-01-25 | |
reported | Eisai Inc. | NCT01972529 | A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure [pACT] | 2017-01-26 | |
reported | Pearl Therapeutics, Inc. | NCT02643082 | A Randomized, Double-Blind, Two Treatment, Two Period, Chronic Dosing (2 Weeks), Cross-Over, Single-Center Study to Evaluate the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD [pACT] | 2017-01-26 | |
reported | Hoffmann-La Roche | NCT02604342 | Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase-Positive Advanced Non Small Cell Lung Cancer Patients Previously Treated With Platinum-Based Chemotherapy and Crizotinib [pACT] | 2017-01-26 | |
reported | Ferring Pharmaceuticals | NCT02554279 | A Randomized, Assessor-blind Trial Comparing MENOPUR® (Menotropins for Injection) and Recombinant FSH (Follicle Stimulating Hormone) in a GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population [pACT] | 2017-01-26 | |
reported | Novartis Pharmaceuticals | NCT01582061 | An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease (Seascape). [pACT] | 2017-01-26 | |
reported | Massachusetts General Hospital | NCT01783574 | Collaborative Study: Testosterone Antidepressant Augmentation in Women [pACT] | 2017-01-27 | |
reported-late | Psoriasis Treatment Center of Central New Jersey | NCT02985736 | An Open-Label, Study Evaluating Topicort® Topical Spray 0.25% (Desoximetasone) in Patients With Scalp Psoriasis [pACT] | 2017-01-27 | 69 |
overdue | Melinta Therapeutics, Inc. | NCT02510599 | An Open Label, Proof of Principle Study to Evaluate the Efficacy and Safety of Solithromycin for the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis [pACT] | 2017-01-27 | 1474 |
reported-late | National Cancer Institute (NCI) | NCT02134925 | Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Vaccine in Patients With Newly Diagnosed Advanced Adenomas [pACT] | 2017-01-27 | 47 |
reported | Bristol-Myers Squibb | NCT02472977 | A Phase 1/2 Study of the Safety and Efficacy of Ulocuplumab Combined With Nivolumab in Subjects With Advanced or Metastatic Solid Tumors [pACT] | 2017-01-27 | |
reported-late | University of California, San Francisco | NCT02147301 | Prospective Phase II Study of Chemoembolization With Doxorubicin-Eluting Microspheres for Liver Transplantation Candidates With Hepatocellular Carcinoma and Marginal Hepatic Reserve [pACT] | 2017-01-27 | 431 |
reported-late | Diva De Leon | NCT00835328 | Role of Glucagon-Like Peptide-1 (GLP-1) in Congenital Hyperinsulinism: Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia [pACT] | 2017-01-28 | 771 |
reported-late | Sanofi Pasteur, a Sanofi Company | NCT02451358 | Immunogenicity and Safety of a Single Dose or Two Doses Given 28 Days Apart of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Subjects Aged 6 Months or Older in India [pACT] | 2017-01-28 | 1 |
reported-late | M.D. Anderson Cancer Center | NCT01444742 | Clofarabine Plus Low-Dose Cytarabine for the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome (MDS) Who Have Been Relapsing After, or Are Refractory to, Hypomethylator Therapy [pACT] | 2017-01-29 | 43 |
reported | OhioHealth | NCT02266875 | Nebulized Hypertonic Saline for Inpatient Use in Chronic Obstructive Pulmonary Disease [pACT] | 2017-01-30 | |
reported-late | Motif Bio | NCT02600611 | A Phase 3, Randomized, Double-blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of ABSSSI: REVIVE-1 [pACT] | 2017-01-30 | 49 |
reported | AEterna Zentaris | NCT01767155 | Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer. [pACT] | 2017-01-30 | |
reported | Eisai Inc. | NCT01976104 | A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure [pACT] | 2017-01-30 | |
reported-late | National Cancer Institute (NCI) | NCT00390325 | Phase II Study of Sorafenib (BAY 43-9006) in Patients With Metastatic Medullary Thyroid Carcinoma [pACT] | 2017-01-30 | 98 |
reported-late | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | NCT01578551 | A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Previously Untreated Advanced/Metastatic Pulmonary Adenocarcinoma [pACT] | 2017-01-31 | 230 |
reported-late | Acacia Pharma Ltd | NCT02646566 | Randomised, Double-blind, Placebo-controlled Study of APD421 (Amisulpride for IV Injection) as Treatment of Established Post-operative Nausea and Vomiting, in Patients Who Have Had Prior Prophylaxis [pACT] | 2017-01-31 | 238 |
reported-late | National Cancer Institute (NCI) | NCT01638546 | A Multi-Center, Randomized, Double-Blind Phase II Study Comparing ABT-888, a PARP Inhibitor, Versus Placebo With Temozolomide in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer [pACT] | 2017-01-31 | 27 |
reported | Zosano Pharma Corporation | NCT02745392 | Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine [pACT] | 2017-01-31 | |
reported-late | University of Minnesota | NCT02132520 | A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined Repetitive Transcranial Magnetic Stimulation and Brain-Computer Interface Training [pACT] | 2017-01-31 | 252 |
reported | UCB BIOSCIENCES GmbH | NCT01465997 | A Multicenter, Double-blind, Double-dummy, Follow up Study Evaluating the Long-term Safety of Lacosamide in Comparison With Controlled-release Carbamazepine Used as Monotherapy in Subjects With Partial-onset or Generalized Tonic-clonic Seizures ≥16 Years of Age Coming From the SP0993 Study. [pACT] | 2017-01-31 | |
reported-late | Grifols Therapeutics LLC | NCT02093221 | A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus [pACT] | 2017-01-31 | 51 |
reported-late | Acorda Therapeutics | NCT02422940 | An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits . [pACT] | 2017-01-31 | 6 |
reported | Icahn School of Medicine at Mount Sinai | NCT02389894 | Neuroprotection In Patients Undergoing Aortic Valve Replacement [pACT] | 2017-01-31 | |
overdue | Alcobra Ltd. | NCT02477748 | A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [pACT] | 2017-01-31 | 2200 |
reported-late | George Clinical Pty Ltd | NCT01759303 | A Phase II Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung [pACT] | 2017-01-31 | 1247 |
reported | Dana-Farber Cancer Institute | NCT01185509 | A Phase II, Single Arm, Open Label Study to Evaluate the Efficacy and Safety of Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With Human Epidermal Growth Factor-2 (HER2) Negative Primary Tumors and HER2 Positive Circulating Tumor Cells [pACT] | 2017-01-31 | |
reported-late | Columbia University | NCT02498483 | Acetaminophen and Post Circumcision Pain Control [pACT] | 2017-01-31 | 419 |
overdue | The Maas Clinic | NCT02818556 | A Clinical Study Comparing Restylane® Silk and Belotero Balance® for the Treatment of Superficial, Vertical Perioral Lines [pACT] | 2017-01-31 | 2200 |
overdue | Braintree Laboratories | NCT02820714 | A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation [pACT] | 2017-01-31 | 1470 |
reported | Maturi, Raj K., M.D., P.C. | NCT02357342 | Sirolimus Versus AntiVEGF for Wet AMD [pACT] | 2017-01-31 | |
reported-late | University of California, Davis | NCT01213082 | Phase I/II Prospective, Randomized, Double-blinded Study of Intravitreal Anti-VEGF Therapy Combined With Proton Beam Radiation Versus Sham Irradiation in Treating Exudative Age-related Macular Degeneration [pACT] | 2017-01-31 | 96 |
reported | H. Lundbeck A/S | NCT02006654 | Randomised, Double-blind, Parallel-group, Placebo-controlled Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor [pACT] | 2017-01-31 | |
overdue | Lumenis Be Ltd. | NCT02621593 | Feasibility of Intense Pulsed Light (IPL) for Reducing Dry Eye Symptoms Caused by Meibomian Gland Dysfunction (MGD) [pACT] | 2017-01-31 | 2200 |
reported-late | XBiotech, Inc. | NCT02357966 | A Phase I-II Study of the Safety and Efficacy of a True Human Antibody, 514G3, in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus [pACT] | 2017-01-31 | 2184 |
overdue | NGM Biopharmaceuticals, Inc | NCT02649062 | Study of the Pharmacodynamics of NGM282 on Colonic Transit, Bile Acid Homeostasis, and Fecal Fat in Subjects With Functional Constipation and Healthy Individuals [pACT] | 2017-01-31 | 1470 |
reported-late | Tufts University School of Dental Medicine | NCT02133326 | Assessment of Preemptive Analgesic Effect of Caldolor® vs. Ofirmev® on Third Molar Surgery: A Prospective, Randomized, Double-blinded Clinical Trial [pACT] | 2017-01-31 | 104 |
reported | Massachusetts General Hospital | NCT01920555 | Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) [pACT] | 2017-01-31 | |
reported-late | M.D. Anderson Cancer Center | NCT01746043 | A Randomized Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer [pACT] | 2017-01-31 | 51 |
reported-late | Augusta University | NCT01313416 | A Pilot Study to Test the Feasibility of the Combination of Gemcitabine and Anti-PD1 Monoclonal Antibody (CT-011) in the Treatment of Resected Pancreatic Cancer [pACT] | 2017-01-31 | 503 |
reported-late | University of Wisconsin, Madison | NCT02252666 | Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS) [pACT] | 2017-01-31 | 469 |
reported-late | University of Texas Southwestern Medical Center | NCT01656187 | Attenuation of Corticosteroid Induced Hippocampal Changes [pACT] | 2017-01-31 | 343 |
overdue | Arnold, George, M.D. | NCT00777439 | An Investigational New Drug Program for the Use of Domperidone in the Treatment of Refractory Gastroesophageal Reflux Disease and Other Gastrointestinal Motility Disorders [pACT] | 2017-01-31 | 2200 |
overdue | SurModics, Inc. | NCT02648620 | A Prospective, Multi-Center, Single-Arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects With De Novo Lesions of the Femoropopliteal Artery [pACT] | 2017-01-31 | 1470 |
reported | Eli Lilly and Company | NCT02246621 | A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) Plus LY2835219, a CDK4/6 Inhibitor, or Placebo in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer With No Prior Systemic Therapy in This Disease Setting [pACT] | 2017-01-31 | |
reported-late | Albert Einstein College of Medicine | NCT01269034 | New Onset Type 1 Diabetes: Role of Exenatide [pACT] | 2017-01-31 | 954 |
reported | Sanofi | NCT01571284 | A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen [pACT] | 2017-01-31 | |
reported | National Cancer Institute (NCI) | NCT02042443 | Randomized Phase II Trial of Single Agent MEK Inhibitor Trametinib (GSK1120212) Vs 5-Fluorouracil or Capecitabine in Refractory Advanced Biliary Cancer [pACT] | 2017-01-31 | |
reported-late | Auris Medical, Inc. | NCT01934010 | AM-101 in the Post-Acute Treatment of Peripheral Tinnitus 1 (AMPACT1) - an Open-Label Extension to the TACTT2 Study [pACT] | 2017-01-31 | 8 |
reported-late | University of Colorado, Denver | NCT01935336 | A Phase II Study of Ponatinib in Cohorts of Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers [pACT] | 2017-01-31 | 1160 |
overdue | FORUM Pharmaceuticals Inc | NCT01969136 | A Randomized, Double-blind, Placebo-controlled, Parallel-Group, 26-Week, Phase 3 Study of 2 Doses of EVP-6124 or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication [pACT] | 2017-01-31 | 2200 |
reported-late | Mayo Clinic | NCT02033876 | Effect of Delayed-Release Ursodeoxycholic Acid on Insulin Sensitivity, Gastric Emptying and Body Weight in Overweight or Obese Patients With Type 2 Diabetes on Metformin Treatment [pACT] | 2017-01-31 | 442 |
overdue | Korea University Guro Hospital | NCT03838497 | Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults in the Era of Highly Active Antiretroviral Therapy: Analysis Stratified by CD4 T-cell Count [pACT] | 2017-01-31 | 2200 |